About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Stroke is a medical emergency and a leading cause of death and disability worldwide affecting millions of subjects. In this context the Neurovascular Research Laboratory was created in 2001 focused in stroke research from a basic and translational perspective, covering all stages of the disease: from prevention and treatment, to recovery.
Nowadays our team is composed by a highly motivated group of researchers including clinical and basic scientists, with group leaders involved in National and International projects with public or private research funding on biomarkers for clinical decision making in stroke, the presence of silent infarctions, the assessment of cognition and cognitive decline, developing experimental models of cerebral ischemia testing new treatments complementary to reperfusion, and developing studies on cerebral amyloid angiopathy, tissue neurorepair or post-stroke rehabilitation.
Complementary studies on vascular dementia and Alzheimer disease related to amyloid-beta protein have also been encompassed as part of our research in the last years.
PMID: 34747975 Journal: JAMA Neurology Year: 2022 Reference: JAMA Neurol. 2022 Jan 1;79(1):22-31. doi: 10.1001/jamaneurol.2021.4082. Impact factor: 18.302 Publication type: Paper in international publication Authors: Salazar-Marioni, Sergio, Kuhn, Anna L, Kaliaev, Artem, Farzin, Behzad, Boisseau, William, Masoud, Hesham E, Lopez, Carlos Ynigo, Rana, Ameena, Kareem, Samer Abdul, Sathya, Anvitha et al. DOI: 10.1001/jamaneurol.2021.4082
PMID: 33682453 Journal: STROKE Year: 2021 Reference: Stroke. 2021 May;52(5):1751-1760. doi: 10.1161/STROKEAHA.120.031800. Epub 2021 Mar 8. Impact factor: 7.914 Publication type: Paper in international publication Authors: Garcia-Tornel, Alvaro, Campos, Daniel, Rubiera, Marta, Boned, Sandra, Olive-Gadea, Marta, Requena, Manuel, Ciolli, Ludovico, Muchada, Marian, Pagola, Jorge, Deck, Matias et al. DOI: 10.1161/STROKEAHA.120.031800
PMID: 33674361 Journal: NEUROLOGY Year: 2021 Reference: Neurology. 2021 Apr 13;96(15):e1928-e1939. doi: 10.1212/WNL.0000000000011742. Epub 2021 Mar 5. Impact factor: 9.91 Publication type: Paper in international publication Authors: Sanchez, Jean Charles, Montaner, Joan, Vivien, Denis, Ribo, Marc, Pecharroman, Emili, Bustamante, Alejandro, Penalba, Anna, Orset, Cyrille, Azurmendi, Leire, Llombart, Victor et al. DOI: 10.1212/WNL.0000000000011742
PMID: 33652289 Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES Year: 2021 Reference: J Neurol Sci. 2021 Apr 15;423:117368. doi: 10.1016/j.jns.2021.117368. Epub 2021 Feb 23. Impact factor: 3.181 Publication type: Paper in international publication Authors: Llaurado, Arnau, Quintana, Manuel, Ballve, Alejandro, Campos, Daniel, Fonseca, Elena, Abraira, Laura, Santamarina, Estevo, Toledo, Manuel et al. DOI: 10.1016/j.jns.2021.117368
PMID: 33634708 Journal: Journal of the American Heart Association Year: 2021 Reference: J Am Heart Assoc. 2021 Feb;10(5):e018946. doi: 10.1161/JAHA.120.018946. Epub 2021 Feb 26. Impact factor: 5.501 Publication type: Paper in international publication Authors: Faura, Julia, Bustamante, Alejandro, Reverte, Silvia, Garcia-Berrocoso, Teresa, Millan, Monica, Castellanos, Mar, Lara-Rodriguez, Blanca, Zaragoza, Josep, Ventura, Oriol, Hernandez-Perez, Maria et al. DOI: 10.1161/JAHA.120.018946
PMID: 32404034 Journal: STROKE Year: 2020 Reference: Stroke. 2020 Jun;51(6):1736-1742. doi: 10.1161/STROKEAHA.120.029212. Epub 2020 May 14. Impact factor: 7.19 Publication type: Paper in international publication Authors: Rubiera, Marta, Garcia-Tornel, Alvaro, Olive-Gadea, Marta, Campos, Daniel, Requena, Manuel, Vert, Carla, Pagola, Jorge, Rodriguez-Luna, David, Muchada, Marian, Boned, Sandra et al. DOI: 10.1161/STROKEAHA.120.029212
PMID: 32390548 Journal: STROKE Year: 2020 Reference: Stroke. 2020 Jun;51(6):1766-1771. doi: 10.1161/STROKEAHA.119.028586. Epub 2020 May 11. Impact factor: 7.19 Publication type: Paper in international publication Authors: Rubiera, Marta, Molina, Carlos A, Tomasello, Alejandro, Ribo, Marc, Hernandez, David, Rodriguez-Luna, David, Pagola, Jorge, Coscojuela, Pilar, Requena, Manuel, Olive, Marta et al. DOI: 10.1161/STROKEAHA.119.028586
PMID: 32340244 Journal: Biomolecules Year: 2020 Reference: Biomolecules. 2020 Apr 23;10(4). pii: biom10040651. doi: 10.3390/biom10040651. Impact factor: 4.082 Publication type: Paper in international publication Authors: Ruiz-Meana, Marisol, Valls-Lacalle, Laura, Consegal, Marta, Barba, Ignasi, Ferreira-Gonzalez, Ignacio, Rodriguez-Sinovas, Antonio, Inserte, Javier, Benito, Begona et al. DOI: 10.3390/biom10040651
PMID: 32322099 Journal: Nature Reviews Neurology Year: 2020 Reference: Nat Rev Neurol. 2020 May;16(5):247-264. doi: 10.1038/s41582-020-0350-6. Epub 2020 Apr 22. Impact factor: 27 Publication type: Review in international publication Authors: Tiedt, Steffen, Montaner, Joan, Ramiro, Laura, Simats, Alba, Debette, Stephanie, Sanchez, Jean-Charles, Bustamante, Alejandro, Jickling, Glen C, Makris, Konstantinos et al. DOI: 10.1038/s41582-020-0350-6
PMID: 30776698 Journal: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY Year: 2019 Reference: Seizure. 2019 Mar;66:31-35. doi: 10.1016/j.seizure.2019.02.004. Epub 2019 Feb 8. Impact factor: 2.765 Publication type: Paper in international publication Authors: Toledo, Manuel, Sarria, Silvana, Abraira, Laura, Gramegna, Laura Ludovica, Quintana, Manuel, Santamarina, Estevo, Salas-Puig, Javier, Rovira, Alex et al. DOI: 10.1016/j.seizure.2019.02.004
PMID: 30763767 Journal: EPILEPSY & BEHAVIOR Year: 2019 Reference: Epilepsy Behav. 2019 Mar;92:327-331. doi: 10.1016/j.yebeh.2018.12.008. Epub 2019 Feb 11. Impact factor: 2.378 Publication type: Paper in international publication Authors: Olive-Gadea, Marta, Requena, Manuel, Fonseca Hernandez, Elena, Quintana, Manuel, Santamarina, Estevo, Abraira Del Fresno, Laura, Alvarez-Sabin, Jose, Salas-Puig, Xavier, Toledo, Manuel et al. DOI: 10.1016/j.yebeh.2018.12.008
PMID: 30687923 Journal: REVISTA DE NEUROLOGIA Year: 2019 Reference: Rev Neurol. 2019 Feb 1;68(3):132-133. Impact factor: 0.485 Publication type: Letter whit IF Authors: Llaurado-Gayete, A, Campos-Fernandez, D, Olive-Gadea, M, Ballve-Martin, A, Rio, J, Rovira, A, Santamarina, E et al. DOI: 10.33588/rn.6803.2018377
PMID: 30658321 Journal: EPILEPSY & BEHAVIOR Year: 2019 Reference: Epilepsy Behav. 2019 Mar;92:135-139. doi: 10.1016/j.yebeh.2018.10.043. Epub 2019 Jan 15. Impact factor: 2.378 Publication type: Paper in international publication Authors: Puig, Josep, Abraira, Laura, Iniesta, Marc, Salas-Puig, Xavier et al. DOI: 10.1016/j.yebeh.2018.10.043
The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.
The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.
La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.
